The importance of defining serum MMP-9 concentration in diabetics as an early marker of the rupture of atheromatous plaque in acute coronary syndrome

Acta Physiologica Hungarica

Volumn 98, Issue 1, 2011, Pages 91-97

  Gostiljac, D ^a   Dorevic P ^a   Djurić, Dragan ^a,c   Perunicic J ^a   Lasica, R ^a   Colak E ^b   Canovic, F ^a   Sreckovic V ^a   Ilic M ^a   Obrenovic R ^b  

^a UNIVERSITY OF BELGRADE   (Serbia)

^b CLINICAL CENTER OF SERBIA   (Serbia)

^c UNIVERSITY OF BELGRADE   (Serbia)

Author keywords

acute coronary syndrome atherosclerosis; diabetes mellitus; MMP 9

Indexed keywords

ANTIDIABETIC AGENT; CHOLESTEROL; CREATINE KINASE; CREATININE; GELATINASE B; GLUCOSE; GLUTATHIONE PEROXIDASE; HEMOGLOBIN A1C; HIGH DENSITY LIPOPROTEIN; HIGH DENSITY LIPOPROTEIN 2; HIGH DENSITY LIPOPROTEIN 3; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; INSULIN; LIPID; LOW DENSITY LIPOPROTEIN; SUPEROXIDE DISMUTASE; TRIACYLGLYCEROL; TROPONIN;

ACUTE CORONARY SYNDROME; ADULT; AGED; ARTICLE; ATHEROSCLEROSIS; ATHEROSCLEROTIC PLAQUE; COMORBIDITY; DIABETES MELLITUS; DIABETIC PATIENT; DIAGNOSTIC VALUE; DISEASE MARKER; EARLY DIAGNOSIS; ENZYME BLOOD LEVEL; FEMALE; GLUCOSE BLOOD LEVEL; HUMAN; HYPERLIPIDEMIA; LIPID BLOOD LEVEL; MAJOR CLINICAL STUDY; MALE; RANDOMIZED CONTROLLED TRIAL;

ACUTE CORONARY SYNDROME; AGED; BIOLOGICAL MARKERS; CORONARY ARTERY DISEASE; DIABETES MELLITUS; FEMALE; HUMANS; MALE; MATRIX METALLOPROTEINASE 9; MIDDLE AGED; MYOCARDIAL INFARCTION; PLAQUE, ATHEROSCLEROTIC;

EID: 79952613005     PISSN: 0231424X     EISSN: 15882683     Source Type: Journal    
DOI: 10.1556/APhysiol.98.2011.1.11     Document Type: Article

References (12)

1. Kadoglou NP, Daskalopoulou SS, Perrea D, Liapis CD: Matrix metalloproteinases and diabetic vascular complications. Angiology 56/2, 173-189 (2005) (Pubitemid 40404472)
2. Booth GL, Kapral MK, Fung K, Tu JV: Recent trends in cardiovascular complications among men and women with and without diabetes. Diabetes Care 29, 32-37 (2006) (Pubitemid 44033427)
3. Scognamiglio R, Negut C, Ramondo A et al.: Detection of coronary artery disease in asymptomatic patients with type 2 diabetes mellitus. J. Am. Coll. Cardiol. 47/1, 65-71 (2006) (Pubitemid 43005166)
4. Kai H, Ikeda H, Yasukawa H, Kai M, Seki Y, Kuwahara F, Ueno T, Sugi K, Imaizumi T: Peripheral blood levels of matrix metalloproteases-2 and -9 are elevated in patients with acute coronary syndromes. J. Am. Coll. Cardiol. 32, 368-372 (1998) (Pubitemid 28396484)
5. Mtairag EM, Chollet-Martin S, Oudghiri M et al.: Effects of interleukin-10 on monocyte/endothelial cell adhesion and MMP-9/TIMP-1 secretion. Cardiovasc. Res. 49, 882-890 (2001) (Pubitemid 32178392)
6. Ardans JA, Blum A, Mangan PR et al.: Raloxifene-mediated increase in matrix metalloproteinase-1 production by activated monocytes. Arterioscler. Thromb. Vasc. Biol. 21, 1265-1268 (2001) (Pubitemid 34219830)
7. Noji Y, Kajinami K, Kawashiri M et al.: Circulating matrix metalloproteinases and their inhibitors in premature coronary atherosclerosis. Clin. Chem. Lab. Med. 39, 380-384 (2001) (Pubitemid 32529917)
8. Blankenberg S, Rupprecht HJ, Poirier O, Bickel C, Smieja M, Hafner G et al.: Plasma concentrations and genetic variation of matrix metalloproteinase 9 and prognosis of patients with cardiovascular disease. Circulation 107, 1579-1585 (2003) (Pubitemid 36397324)
9. Tayebjee MH, Lip GY, Tan KT, Patel JV, Hughes EA, MacFadyen RJ: Plasma matrix metalloproteinase-9, tissue inhibitor of metalloproteinase-2, and CD40 ligand levels in patients with stable coronary artery disease. Am. J Cardiol. 96, 339-345 (2005) (Pubitemid 41058855)
10. Noji Y, Kajinami K, Kawashiri MA, Todo Y, Horita T, Nohara A et al.: Circulating matrix metalloproteinases and their inhibitors in premature coronary atherosclerosis. Clin. Chem. Lab. Med. 39, 380-384 (2001) (Pubitemid 32529917)
11. Inokubo Y, Hanada H, Ishizaka H, Fukushi T, Kamada T, Okumura K: Plasma levels of matrix metalloproteinase-9 and tissue inhibitor of metalloproteinase-1 are increased in the coronary circulation in patients with acute coronary syndrome. Am. Heart. J. 141, 211-217 (2001) (Pubitemid 32128725)
12. Uemura S, Matsushita H, Wei L et al.: Diabetes mellitus enhanced vascular matrix metalloproteinase activity: role of oxidative stress. Circ. Res. 8, 1291-1298 (2001) (Pubitemid 32587846)